Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
<strong>Objectives:</strong> Controlled immune responses rely on integrated crosstalk between cells and their microenvironment. We investigated whether targeting proinflammatory signals from the extracellular matrix that persist during pathological inflammation provides a viable strategy...
Main Authors: | Aungier, S, Cartwright, A, Schwenzer, A, Marshall, J, Dyson, M, Slavny, P, Parthiban, K, Karatt-Vellatt, A, Sahbudin, I, Culbert, E, Hextall, P, Clanchy, F, Williams, R, Marsden, B, Raza, K, Filer, A, Buckley, C, McCafferty, J, Midwood, K |
---|---|
格式: | Journal article |
出版: |
BMJ Publishing Group
2018
|
相似書籍
-
Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al.
由: Aungier, S, et al.
出版: (2019) -
Potent anti‐inflammatory effects of the narrow spectrum kinase inhibitor RV1088 on rheumatoid arthritis synovial membrane cells
由: To, W, et al.
出版: (2015) -
Basics of Antibody Phage Display Technology
由: Line Ledsgaard, et al.
出版: (2018-06-01) -
Detection of antibodies to citrullinated tenascin-C in patients with early synovitis is associated with the development of rheumatoid arthritis
由: Raza, K, et al.
出版: (2016) -
Ibudilast inhibits chemokine expression in rheumatoid synovial fibroblasts and exhibits immunomodulatory activity in experimental arthritis
由: Clanchy, F, et al.
出版: (2018)